NEOSTIGMINE METHYLSULFATE INJECTION SDZ
NEOSTIGMINE METHYLSULFATE INJECTION SDZ
Discontinued
DIN Number
02385228
Drug Class
Human
Market Date
N/A
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02385228
AIG Number0102263004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07AA01 NEOSTIGMINE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
,
Intramuscular
,
Intravenous
AHFS Classification12:04.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
NEOSTIGMINE METHYLSULFATEActive
Strength: 2.5 MG / ML
Monograph: NEOSTIGMINE METHYLSULFATE